About EG 427
EG 427 is a French biotechnology company working on “pinpoint gene therapy.” They use a special virus to treat problems in the nervous system, focusing mainly on treating bladder issues caused by nerve problems.
Legal Name
: EG 427
Headquarters
: Paris, France
Business Model
:
Founding Date
: 1970
No. of Employees
:
Founding Members
Related Post
EG 427 funding news – Paris-based EG 427 Secures €27 Million in Series B Round Funding
Vortexa funding news – London-based Vortexa Raises $25 million in Strategic Debt Financing
Europe Weekly Startup Funding News Report For Monday, 10 March 2025 to Saturday, 15 March 2025
Biotech
EG 427
Pinpoint Gene Therapy
Ignota Labs
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients.
France
EG 427
Pinpoint Gene Therapy
Contact us: contact@startuprise.co.uk